Skip to main content

In-Vitro Fertilization Market is predicted to grow at a CAGR of 9.37% during 2020-2030.

Healthcare specialists have located in-vitro fertilization to be one of the most hastily evolving techniques, and the world market for in-vitro fertilization is anticipated to develop at a CAGR of 9.37% over the forecast length 2020-2030. An make bigger in the fashion of delayed pregnancies, altering life in city areas, and accelerated age of parenthood bolster the increase of the world IVF market. The following record gives the reader with an possibility to liberate complete insights with respect to the international IVF market and helps in forming well-informed strategic decisions. The market lookup learn about additionally provides a vast standpoint of the one of a kind kinds of merchandise and offerings on hand in the market and their have an impact on on the healthcare zone through offering crucial insights into the path of its future expansion.

The market value estimated by 2030 will be $51,505.1 Million. The in-vitro fertilization market in the coming years is expected to grow at a CAGR of 9.37% during the forecast period from 2020-2030.



Market Segmentation

•    Component – Product, Services

•    Product – Systems, Media and Reagents, Accessories and Consumables

•    Services – Types, Procedures, End Users


Regional Segmentation

•    North America – U.S., Canada

•    Europe – Germany, France, Italy, U.K., Spain, Russia, Netherlands

•    Asia-Pacific – Japan, China, India, South Korea, Australia, Singapore

•    Latin America – Brazil, Mexico

•    Rest-of-the-World – the Middle East and Africa


Growth Drivers

•    Growth in Median Age of First-Time Motherhood and Declining Fertility Rates

•    High Success Rate of IVF Treatment

•    Increasing Demand for Infertility Treatment to Support Aging Population

•    Impact of Fertility Tourism


Market Challenges

•    Unaffordable Cost of Assisted Reproductive Techniques (ART) and Genetic Testing in Low- and Middle- Income Countries

•    Lack of Guidelines and Regulations, and Low Awareness of IVF Treatment in Some Under-Developed and Developing Nations

•    Ethical Issues and Social Justice


Market Opportunities

•    Technological Advancements of Time-Lapse Technology

•    Advances in Embryo Biopsy and Genetic Screening


Key In-Vitro Fertilization Companies Profiled

Suppliers - CooperSurgical, Inc., Vitrolife AB, Illumina, Inc., Agilent Technologies, Inc., Cook Medical Inc., Fujifilm Irvine Scientific Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Abbott Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Esco Micro Pte. Ltd., IVFtech APS, and Kitazato Corporation.

Service Providers - CARE Fertility, Laboratory Corporation of America Holdings, Genea Limited, Natera, Inc., Invitae Corporation, Kaiser Permanente, Progyny, Inc., Boston IVF, and Monash IVF Group.

Request a Sample - https://bisresearch.com/requestsample?id=1106&type=download


Labels:

Comments

Post a Comment

Popular posts from this blog

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applicatio
Post a Comment
Read more

Growing Focus on Patient-Centered Healthcare led to Rise in Urgent Care Apps Market

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring.   Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth.  The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030.   The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of
Post a Comment
Read more

Neoantigen Cancer Vaccine Market Technology Developments and Future Growth

  Looking at the recent oncology care trends, the World Heart Foundation estimates the global cancer treatment expenditure to reach $XX billion in the year 2031.   The increase in overall burden provides an opportunity for several companies to step in and introduce their innovative products in the market. The emergence of the neoantigen cancer vaccine can be considered as an evident example of emerging oncology care that can possibly prevail over the existing hurdles of treatment un-specificity and safety benchmarks. The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031. The  neoantigen cancer vaccine market  is expected to generate $35.5 million in revenue in 2024, owing to the expected launch of the first neoantigen vaccine, DC vaccine in the market. The neoantigen cancer vaccine market growth has been primarily attributed to major drivers in this market, such as rising p
Post a Comment
Read more